PURPOSE: to subject 4-methylamphetamine to control measures.
NON-LEGISLATIVE ACT: Council Implementing Decision (EU) 2015/1874 on subjecting 4-methylamphetamine to control measures.
CONTENT: the Council adopted an implementing decision on subjecting 4-methylamphetamine to control measures across the Union.
4-methylamphetamine is a synthetic ring-methylated derivative of amphetamine. It has emerged on the illicit amphetamine market where it is sold and used as the controlled drug, amphetamine.
Decision 2005/387/JHA confers upon the Council implementing powers with a view to giving a quick and expertise-based response at Union level to the emergence of new psychoactive substances detected and reported by the Member States, by subjecting those substances to control measures across the Union.
A risk assessment report on 4-methylamphetamine was drawn up in accordance with Decision 2005/387/JHA by a special session of the extended Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
The report revealed that there is limited scientific evidence available on the characteristics and risks of 4-methylamphetamine and points out that further studies are required on the overall health and social risks associated with the substance. However, the evidence available provides sufficient grounds for subjecting 4-methylamphetamine to control measures across the Union.
Decision 2013/129/EU ceases to produce effects as of the day of entry into force of this Decision, without prejudice to the obligations of the Member States relating to the time limit for subjecting that new psychoactive substance to control measures and criminal penalties in their national laws.
ENTRY INTO FORCE: 21.10.2015.